docevaluation report - Virology Education
download 
Denúncia Transcrição
evaluation report - Virology Education
4TH LATIN AMERICAN MEETING ON TREATMENT OF VIRAL HEPATITIS AND HIV CO-INFECTION TREATMENT OF VIRAL HEPATITIS AND HIV CO-INFECTION SÃO PAULO, BRAZIL • 20-21 MARCH 2015 EVALUATION REPORT www.virology-education.com EXECUTIVE SUMMARY The annual Latin American Meeting on Treatment of Viral Hepatitis was initiated four years ago and is recognized as a unique and important educational meeting for caregivers in the field of Hepatitis C. Given the many changes in the field of Viral Hepatitis and the urgent need for education of practising clinicians in Latin America, we have established a Latin American program for scientific exchange and education in collaboration with national and international Key Opinion Leaders. The workshop is focused on the most recent developments in clinical management of Viral Hepatitis and brings together infectious diseases doctors and hepatologists as well as other healthcare professionals involved in treating HCV and co-infected patients. This year’s edition was again a unique high profile educational event with the contribution of key opinion leaders. The Program and Scientific Committee had set up a program for treating physicians to discuss the latest developments in the field of Hepatitis B and C treatment and the promising treatment possibilities of new antivirals that are becoming available. The conference presentations were focused on the translation of these new data and availability of new drugs into daily clinical practice. IMPACT The workshop was very well received, which is reflected by the evaluation results. 89% of the respondents indicated that this workshop has enhanced their professional effectiveness. Lastly, 88% of the clinicians responded that they will improve their daily practice as a result of attending this conference. PARTICIPANTS BACKGROUND Mainly employed by: Government 13% NGO Other 4% 0% Occupation: University 9% Researcher 5% Attention was drawn to this workshop by: Other 5% Pharma 6% Hospital 68% Medical doctor 90% Colleague / word of mouth 4% Returning participant 10% VE website 15% Invite form the industry 54% VE email announcements 11% VE flyer 4% Flyer at other meetings 2% PROGRAM The program included 10 invited lectures, 2 oral abstract presentations, a clinical case presentation and a round table discussion. Ample time was allocated for discussions. The evaluation scores of the presentations can be found on pages 9, 10 and 11. ABSTRACTS The Organizing Committee accepted 2 abstracts, which have both been selected for an oral presentation. The repondents confirmed that the topics of the abstracts were interesting (69%) and that the content was relevant to their work (59%) 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 2 CONTENT Executive Summary............................................................................... 2 Introduction............................................................................................ 4 Background..............................................................................................4 Format.....................................................................................................4 Target audience.......................................................................................4 Meeting Objectives...................................................................................4 Learning Objectives.................................................................................4 Acknowledgements............................................................................... 5 Program Committee.............................................................................. 6 Scientific committee.............................................................................. 7 Participants’ Feedback 2015.................................................................. 8 Learning objectives..................................................................................8 Impact......................................................................................................8 Lectures...................................................................................................9 Logistics.................................................................................................12 General Workshop experience..............................................................12 Publicity.................................................................................................12 Meeting demographics.........................................................................13 Number of Participants.........................................................................13 Professional background.......................................................................13 METRICS 2015.......................................................................................14 Abstracts................................................................................................14 Pre-workshop communications............................................................14 Post-workshop communications...........................................................14 Conclusion............................................................................................15 List of Participants................................................................................16 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 3 INTRODUCTION The 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection was held on 20-21 March 2015 in the Tivoli Mofarrej Hotel in São Paulo, Brazil. The Program and Scientific Committee and the Organizing Secretariat highly value the opinion of the participants in order to further improve the quality of the workshop. Participants were asked to complete an evaluation form to share their opinion on several subjects. BACKGROUND Currently, many exciting developments are taking place in the field of Hepatitis C treatment and the new Antivirals that are becoming available provide promising new treatment possibilities. However, it is of crucial importance that the knowledge that is available among the experts in the field is translated to clinical practice. It is therefore that we have initiated a true educational platform for caregivers in the field of Hepatitis C treatment which provides an opportunity to be educated on all aspects of the new antivirals and most importantly on how to implement these new antivirals in daily practice. The mission of this annual medical conference is to provide a Latin American, independent and scientific platform for healthcare professionals involved in treatment of Viral Hepatitis, such as clinicians, researchers, nurses, Post-docs, government employees, industry representatives and other professionals, where they share and discuss the latest developments in the field and the implications for daily practice. FORMAT This two-day international scientific and educational workshop consists of invited lectures by key opinion leaders, clinical case presentations, discussions and abstract presentations. In order to ascertain an interactive workshop setting, much time is allocated to discussion. TARGET AUDIENCE This workshop brings together infectious diseases doctors and hepatologists as well as other healthcare professionals involved in treating HCV and co-infected patients. MEETING OBJECTIVES • To provide an independent platform for interchange and education • To provide a scientific and intimate workshop setting in order to stimulate discussion and interaction • To encourage collaborations between disciplines on a national and continental level • To develop new treatment strategies and guidelines LEARNING OBJECTIVES After participating in this activity, the participants will • have an understanding of the basic concepts of viral hepatitis • be updated on the latest developments in the field of hepatitis B and C antiviral research in Latin America • have an understanding of the treatment challenges of hepatitis co-infected patients • have insight in the advantages and possibilities of new antivirals 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 4 ACKNOWLEDGEMENTS The organizers acknowledge the contributions of the sponsors that have made the 4TH LATIN AMERICAN MEETING ON TREATMENT OF VIRAL HEPATITIS AND HIV CO-INFECTION possible: GOLD LEVEL SPONSORS SILVER LEVEL SPONSOR PRINCIPAL SUPPORTER CONTRIBUTOR Gilead Sciences Brazil 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 5 PROGRAM COMMITTEE CHARLES BOUCHER, MD, PHD Erasmus Medical Center The Netherlands DAVID KERSHENOBICH STALNIKOWITZ, MD, PHD Instituto Nacional de Ciencias Médicas y Nutrición Salvador Mexico MAURO SCHECHTER, MD, PHD Federal University of Rio de Janeiro Brazil MARCELO SILVA, MD University Hospital Austral Argentina EVALUATION REPORT 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20 - 21 March 2015, São Paulo, Brazil 6 SCIENTIFIC COMMITTEE Maria Butí, MD, PhD ����������������������������������������������������������������� Hospital Vall’ Hebron, Spain Pedro Cahn, MD, PhD���������������������������������������������������������������� Fundación Huésped, Argentina Lucy Dagher, MD ����������������������������������������������������������������������� Policlínica Metropolitana, Venezuela Milagros Davalos, MD���������������������������������������������������������������� Universidad de Ciências Aplicadas (UCP), Peru Rafael Esteban, MD�������������������������������������������������������������������Hospital Vall’ Hebron, Spain Maria Lucia Ferraz, MD, PhD����������������������������������������������������Federal University of São Paulo, Brazil Nahum Méndez-Sánchez, MD, MSc, PhD���������������������������������President of the ALEH, Mexico Linda Muñoz, MD, PhD��������������������������������������������������������������Universidad Autónoma de Nuevo León, Mexico Raymundo Paraná, MD, PhD�����������������������������������������������������University Hospital of Bahia, Brazil Fred Poordad, MD����������������������������������������������������������������������Texas Liver Institute & Alamo Medical Research, USA Jürgen Rockstroh, MD���������������������������������������������������������������University of Bonn, Germany Alejandro Soza Ried, MD�����������������������������������������������������������Pontificada Universidad Católica de Chile, Chile Stefan Zeuzem, MD �������������������������������������������������������������������JW Goethe University Hospital Frankfurt, Germany EVALUATION REPORT 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20 - 21 March 2015, São Paulo, Brazil 7 PARTICIPANTS’ FEEDBACK 2015 LEARNING OBJECTIVES Strongly agree/ Agree Neutral Diagree/ Strongly disagree After participating in this activity, the participants will • have an understanding of the basic concepts of viral hepatitis 100% - - • be updated on the latest developments in the field of hepatitis B and C antiviral research in Latin America 100% - - • have an understanding of the treatment challenges of hepatitis coinfected patients 88% 12% - • have insight in the advantages and possibilities of new antivirals 100% - - Strongly agree / Agree Neutral Diagree / Strongly disagree Overall, the conference has enhanced my professional effectiveness 89% 11% - As clinician, I will improve my daily practice as a result of attending this conference 88% 6% 6% IMPACT 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 8 PARTICIPANTS’ FEEDBACK 2015 LECTURES FRIDAY 20 MARCH 2015 Session 1: Current Challenges in Treatment of HBV State of the art lecture Maria Butí, MD, PhD Hospital Vall’Hebron, Spain Update on data presented at the CROI/ AASLD Rafael Esteban, MD Hospital Vall’ Hebron, Spain Excellent/Good Average Fair/Poor Topic is interesting 100% - - Content is relevant to my work 97% 3% - Speaker performance 100% - - Excellent/Good Average Fair/Poor Topic is interesting 100% - - Content is relevant to my work 100% - - Speaker performance 100% - - Excellent/Good Average Fair/Poor Topic is interesting 90% 10% - Content is relevant to my work 90% 10% - Speaker performance 90% 10% - Excellent/Good Average Fair/Poor Topic is interesting 62% 28% 9% Content is relevant to my work 42% 36% 23% Excellent/Good Average Fair/Poor Topic is interesting 94% 6% - Content is relevant to my work 86% 14% - Speaker performance 70% 24% 6% Session 2: Clinical Management of HBV Clinical management of HBV - What is happening in Latin America David Kershenobich Stalnikowitz, MD, PhD National Institute of Medical Sciences and Nutrition “Salvador Zubiran”, Mexico Abstract: Clinical, demographic and epidemiological characteristics of hepatitis B virus infected patients of a university public hospital of São Paulo, Brazil Luiz Euribel Prestes-Carneiro Regional Hospital of Presidente Prudente, Brazil Latin American HBV Guidelines Lucy Dagher MD Policlinica Metropolitana, Venezuela 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 9 PARTICIPANTS’ FEEDBACK 2015 Session 3: Future Treatment Options for HBV Future challenges in hepatitis B treatment Maria Butí, MD, PhD Hospital Vall’Hebron, Spain Excellent/Good Average Fair/Poor Topic is interesting 100% - - Content is relevant to my work 94% 6% - Speaker performance 97% 3% - Excellent/Good Average Fair/Poor Topic is interesting 100% - - Content is relevant to my work 88% 12% - Speaker performance 93% 7% - Excellent/Good Average Fair/Poor Topic is interesting 100% - - Content is relevant to my work 100% - - Speaker performance 100% - - SATURDAY 21 MARCH Session 4: Current challenges in Treatment of HCV Treatment challenges in transplant patients Gregory Everson, MD, FACP University of Colorado, USA Current treatment options co-infected patients Jürgen Rockstroh, MD Medizinischen Universitätsklinik, Germany What are the options in Latin America Carlos E. Brandão, MD, PhD Universidade Federal do Rio de Janeiro, Brazil Excellent/Good Average Fair/Poor Topic is interesting 92% 8% - Content is relevant to my work 87% 9% 5% Speaker performance 92% 5% 3% Excellent/Good Average Fair/Poor Topic is interesting 76% 10% 14% Content is relevant to my work 76% - 24% Session 5: Clinical Case presentations - HCV Case Report: Viral escape with Protease Inhibitor “first wave” in naïve patient, should worry about? Ana Paula Serra Leopercio Ambulatório de hepatites e enfermatia, São Paulo, Brazil 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 10 PARTICIPANTS’ FEEDBACK 2015 Clinical case Pedro Cahn, MD, PhD Fundación Huésped, Argentina Excellent/Good Average Fair/Poor Topic is interesting 91% 5% 4% Content is relevant to my work 81% - 19% Excellent/Good Average Fair/Poor Topic is interesting 100% - - Content is relevant to my work 100% - - Speaker performance 96% - 4% Excellent/Good Average Fair/Poor Topic is interesting 92% 8% - Content is relevant to my work 87% 13% - Speaker performance 87% 13% - Excellent/Good Average Fair/Poor Topic is interesting 93% 7% - Content is relevant to my work 87% 13% - Session 6: The Future of Hepatitis Management State of the art lecture on IFN- free treatment option Christophe Hézode, MD, PhD Hôpital Henri Mondor, France Is PrEP for hepatitis an option? Jürgen Rockstroh, MD, PhD - Medizinischen Universitätsklinik, Germany Session 7: Round Table Discussion: Access to Care Pricing strategies Fabio Mesquita, MD, PhD Ministry of Health’s Department of STs, AIDS and Viral Hepatitis, Brazil Community perspective Carlos Varaldo, ME Grupo Otimismo, www.hepato.com 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 11 PARTICIPANTS’ FEEDBACK 2015 LOGISTICS Excellent / Good Average Fair / Poor Content of electronic announcements 85% 12% 3% Frequency of electronic announcements 84% 12% 4% Information of conference website 84% 8% 8% Online registration process 90% 5% 5% Meeting venue 96% 4% - Audiovisuals 100% - - Food & beverage 92% 8% - Translation 75% 25% - Onsite logistics 100% - - Service level of Conference Secretariat 100% - - Excellent /very much Average/neutral Fair /disagree 100% - - Opportunity of networking 65% 35% - Content of the conference 100% - - Time allocation for discussion 100% - - GENERAL MEETING EXPERIENCE agree Overall event experience Time allocation per presentation 100% - - No commercial bias (product selling) perceived 88% 12% - I would recommend this meeting to my peers 94% 6% - I plan to attend this meeting next year 94% 6% - PUBLICITY My attention was drawn to this workshop by…. Colleague / word of mouth 4% Returning participant 10% VE website 15% Invite form the industry 54% I was motivated to attend by: VE email announcements 11% VE flyer 4% Experience from previous edition 12% Opportunity to meet with colleagues 8% Meeting objectives 19% Other 2% Scientific program 59% Flyer at other meetings 2% 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 12 MEETING DEMOGRAPHICS NUMBER OF PARTICIPANTS This year’s edition was attended by 104 participants. The geographical distribution of participants is as follows: Argentina2 The Netherlands 1 Brazil85 The Netherlands Antilles 1 Colombia9 Peru1 France1 Spain2 Germany1 USA1 Mexico2 Venezuela1 PROFESSIONAL BACKGROUND I am: Mainly employed by: Other 5% Researcher 5% Government 13% NGO Other 4% 0% University 9% Pharma 6% Medical doctor 90% Hospital 68% Area of expertise: Other 3% Hepatology 16% Infectious diseases 81% 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 13 METRICS 2015 ABSTRACTS 2015 Total number of accepted abstracts 2 Oral presentations 2 Poster presentations 0 PRE-WORKSHOP COMMUNICATIONS Frequency/ Number Publicity through electronic newsletter 4 Flyers at other meetings ALEH, AASLD, EASL, CROI Communications through partner organizations SADI Other POST-WORKSHOP COMMUNICATIONS Frequency/Number Publication of presentation slides online The slides of the presentations have been made available online at www.infectiousdiseasesonline.com. Publication of abstracts The abstracts are published in the Final Program Book. A total number of 110 have been distributed during the workshop. An online version is available on the Virology Education website, www.virology-eduction.com. Post Conference Newsletter A Post Conference Newsletter with a link to the abstracts and presentation slides has been sent to the participants of this years’ workshop and of previous workshops. Other Grupo Otimismo has published a meeting report summarizing the highlights of the meeting on www.hepato. com. 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 14 CONCLUSION The overall opinion of the meeting was very positive, as can be deducted from the above scores. Participants were satisfied with the scientific content of the meeting as well as with the logistics and the format of the program. We are very pleased with the evaluation results of this meeting. The success and importance of this meeting have underlined the need for continuation. The Program Committee will organize this meeting again in Rio de Janeiro on 14-15 October 2016. 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 15 LIST OF PARTICIPANTS Participant Institute Country Abdala, Edson HXFMUSP Brazil Acel Fanti, Susanna Gilead Sciences Farmaceutica do Brasil LTDA Brazil Acuipil, Carolina Hospital Muñiz Argentina Aires, Elisa Miranda SAE Lapa Brazil Almeida, Andrea IAMSPE Brazil Antunes, Kátia Janssen Farmaceutica LTDA Brazil Armada, Lucia Janssen Farmaceutica LTDA Brazil Asano, Elio Janssen Farmaceutica LTDA Brazil Assis dos Anjos, Guilherme Instituto de Infectologia Emílio Ribas Brazil Azevedo Teixeira, Ralcyon Francis Infectologia Emilio Ribas Brazil Banks Ferreira Lopes, Max Igor Hospital das Clinicas Brazil Barbosa, Rosa Maria IAMSPE Brazil Barbosa, Umbeliana Instituto de Infectologia Emílio Ribas Brazil Barraza, Marcos Consultorio Colombia Benatti, Alexandre Gilead Sciences Farmaceutica do Brasil LTDA Brazil Bergel, Fernando Skazufka Secretaria Municipal de Saúde de Ubatuba. Brazil Bernardini, Antonio Consultorio Brazil Boucher, Charles Erasmus Medical Center The Netherlands Brandão, Carlos Eduardo University of Rio de Janeiro Brazil Brito, Joana Hospital Ipiranga Brazil Brizola de Campos, Priscila PAM Varzea do Carmo Brazil Buti, Maria Hospital Valle Hebron Spain Cahn, Pedro Fundacion Huesped Argentina Callefi, Luciana Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Brazil Caly, Wanda Regina Faculdade de Medicina do ABC Brazil Campagno, Aline Gilead Sciences Farmaceutica do Brasil LTDA Brazil Campos, Anita Gilead Sciences Farmaceutica do Brasil LTDA Brazil Campos, Daniel Abbvie Brazil Cardoso, Rodrigo MSD Brazil Carpi, Glaúcia Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Brazil Castañeda, Carlos Vitalsalud IPS Colombia Castro, Nubia Gilead Sciences Farmaceutica do Brasil LTDA Brazil Cimerman, Sergio Instituto de Infectologia Emílio Ribas Brazil Conte, Caio Gilead Sciences Farmaceutica do Brasil LTDA Brazil Costa, Nilton Janssen Farmaceutica LTDA Brazil Coutinho Nogueira, Adriana IAMSPE Brazil da Rocha Leite, Janaina Maria Hospital São Camilo Brazil 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 16 da Silva, Mariliza Henrique SAE São Bernardo do Campo Brazil Dagher, Lucy Policlinica Metropolitana Venezuela De Bortholi Santos, Edgar Instituto de Infectologia Emílio Ribas Brazil De la Vega, Fernando Hospital Universitario de Cartagena Colombia De Moura Coelho, Ana Carolina Hospital Heliópolis Brazil De Oliveira, Alexandre Janssen Farmaceutica LTDA Brazil Della Negra, Marina Janssen Farmaceutica LTDA Brazil Demarchi, Juliana Janssen Farmaceutica LTDA Brazil Diament, Décio Instituto de Infectologia Emílio Ribas Brazil Dias Prado, Kleber Instituto de Infectologia Emílio Ribas Brazil El Far, Fabiane Gilead Sciences Farmaceutica do Brasil LTDA Brazil Esteban, Rafael Hospital Valle Hebron Spain Euribel Prestes-Carneiro, Luiz Hospital Regional de Presidente Prudente Brazil Everson, Gregory University of Colorado Denver USA Fagundes, Iwarte MSD Brazil Ferreira, Michele Janssen Farmaceutica LTDA Brazil Ferreira, Rodolfo Bristol-Myers Squibb Brazil Ferrufino, Rosario Quiroga Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Brazil Focaccia, Roberto Instituto de Infectologia Emílio Ribas Brazil Fogo, Anelize Janssen Farmaceutica LTDA Brazil Gagliotti Coppola, Debora Hospital Ipiranga Brazil Galante, Virginia Chagas Consult / CRT Brazil Gomes de Sá Ribeiro, Maria de Fatima Hospital Heliópolis Brazil Gomes e Costa, Durval Alex Instituto de Assistencia Nedica AO Brazil Gomez Bernal, Fernando Abbvie Brazil Gomez, Ximena Janssen Cilag S.A. Colombia Gonsalez, Claúdio Instituto de Infectologia Emílio Ribas Brazil Gonzalez Vigani, Aline Unicamp Brazil Guerra Correa, Francini CRT DST/AIDS Brazil Hagge, Edgard Gilead Sciences Farmaceutica do Brasil LTDA Brazil Hanna, Graziella Hospital Nipo Brasileiro Brazil Hézode, Christophe Hôpital Henri Mondor, Université Paris XII France Itoo, Ttheize Gilead Sciences Farmaceutica do Brasil LTDA Brazil Jafet Ourives, Ana Paula Hospital Santa Marcelina Brazil Junger, Daniel National Institute of Infectology Brazil Kershenobich, David National Institute of Medical Sciences and Nutrician Salvador Zubiran Mexico Khoury, Zarifa Instituto de Infectologia Emílio Ribas Brazil Kobal, Christiane CLIMIPI Brazil Konno, Adriana Abbvie Brazil Leopercio, Ana CRT DST/AIDS Brazil 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 17 Magno, Luiz Janssen Farmaceutica LTDA Brazil Mantilla, Monica Saludcoop IPS Colombia Marques de Miranda Rossa, Andrea SAE São Bernardo do Campo Brazil Martins, Karen Gilead Sciences Farmaceutica do Brasil LTDA Brazil Martins, Roseane MSD Brazil Matos, Eduardo Hospital Loayza/MINSA Peru Mazza, Celso Carmo Clinical Medic Brazil Medeiros Almeida Dutra, Lívia IAMSPE Brazil Mello, Fernanda Janssen Farmaceutica LTDA Brazil Mesquita, Fábio Ministério da Saúde Brazil Mies, Sergio Hospital das Clinicas Brazil Miranda rodrigues, Lina HSPE Brazil Mitiko Ouki, Lilian Infectologia Emilio Ribas Brazil Mitre, Heloisa Pedrosa IAMSPE Brazil Miyamoto, Luciana SAE Diadema Brazil Morais, Andre Janssen Farmaceutica LTDA Brazil Moreira, Ricardo Abbvie Brazil Munoz, Linda Universidad Autónoma de Nuevo León Mexico Murilo Buzato Villaron Xavier, José Hospital Ipiranga Brazil Nasciben, Vitor Janssen Farmaceutica LTDA Brazil Olano, Jimena Janssen Cilag S.A. Colombia Oliveira, Luciano Gilead Sciences Farmaceutica do Brasil LTDA Brazil Ospina, Leonardo Hospital Mederi Colombia Ossamu Maki, Marcelo Hospital Santa Marcelina Brazil Pacheco, Sergio Abbvie Brazil Parisi, Caio Abbvie Brazil Passianoto, Marina Abbvie Brazil Pedrosa Barbosa, Fernanda IAMSPE Brazil Pereira Goulart, Silvia SAE Lapa Brazil Pinheiro, Sirleide Uchoa Consultorio Brazil Porto Medeiros, Roseane Conjunto Hospitalar do Mandaqui Brazil Posada, Santiago Janssen Cilag S.A. Colombia Prats, João Antônio UNIFESP Brazil R.P. Neto, Djalma Consultorio Brazil Rabelo, Fabiola Faculdade de Medicina do ABC Brazil Ramos, Claudia Janssen Farmaceutica LTDA Brazil Razzo, Ananda Hospital Santa Marcelina Brazil Rockstroh, Juergen University of Bonn Germany Rodriguez, Lourdes Hospital Almenara/ESSALUD Peru Rojas, Hugo Rombino, Fernanda Colombia Abbvie Brazil 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 18 Rosa, Renan Gilead Sciences Farmaceutica do Brasil LTDA Brazil Rufeisen, Vera Marcia Unicamp Brazil Ruocco, Doménico Janssen Cilag S.A. Colombia Santiago, Claudio Abbvie Brazil Santos Torres, Nivía IAMSPE Brazil Santos, Regina G. Hepato - BP Brazil Santos, Veronica Janssen Farmaceutica LTDA Brazil Sasaki, Marli CRT DST/AIDS Brazil Schechter, Mauro Hospital Universitario Clementino Fraga Filho Brazil Schöntag, Márcia França Abbvie Brazil Sette Junior, Hoel Consultorio Brazil Siroma, Fabiana Instituto de Infectologia Emílio Ribas Brazil Tavares C Gaboardi, Marilia Consultorio Brazil Tavares Salles, Rafael IAMSPE Brazil Taveira dos Santos, Luiz Conjunto Hospitalar do Mandaqui Brazil Tilanus, Alwin St Elisabeth Hospital Netherlands Antilles Trida, Irma Janssen Farmaceutica LTDA Brazil Uribe Granja, Maria Claudia Janssen Cilag S.A. Colombia Varaldo, Carlos Grupo Otimismo de Apoio ao Portador de Hepatite Brazil Vasconcelos, Lucy Consultorio Brazil Vidal Bermudez, Jose Ernesto Instituto de Infectologia Emílio Ribas Brazil Xavier, André MSD Brazil Zambrini, Heverton Abbvie Brazil Zuleima e Silva, Zilda IAMSPE Brazil 4th Latin American Meeting on Treatment of Viral Hepatitis and HIV Co-infection 20-21 March 2015, São Paulo, Brazil 19
